4.5 Review

Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cardiac & Cardiovascular Systems

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC

Theresa A. McDonagh et al.

Summary: All experts involved in the development of the guidelines have declared their interests, and the declarations have been compiled and published in a supplementary report. The report can be accessed on the ESC website. The supplementary data provide background information and detailed discussion of the data that form the basis for the guidelines.

EUROPEAN JOURNAL OF HEART FAILURE (2022)

Article Cardiac & Cardiovascular Systems

Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial

Susana Ravassa et al.

Summary: The HOMAGE randomized trial showed that spironolactone reduced left atrial volume index (LAVI), E:A ratio, and a marker of collagen synthesis in patients at risk of heart failure. Patients with low serum collagen cross-linking benefited more from spironolactone treatment on left atrial remodeling and N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels.

EUROPEAN JOURNAL OF HEART FAILURE (2022)

Review Cardiac & Cardiovascular Systems

The utility of growth differentiation factor-15, galectin-3, and sST2 as biomarkers for the diagnosis of heart failure with preserved ejection fraction and compared to heart failure with reduced ejection fraction: a systematic review

Simon W. Rabkin et al.

Summary: GDF-15, Gal-3, and sST2 levels can be used to diagnose HFpEF and are higher compared to no heart failure. BNP is more effective in differentiating HFrEF from HFpEF. Indices incorporating GDF-15, Gal-3, or sST2 along with BNP show promise in differentiating HFpEF from HFrEF.

HEART FAILURE REVIEWS (2021)

Article Pharmacology & Pharmacy

Increased concentrations of bioactive adrenomedullin subsequently to angiotensin-receptor/neprilysin-inhibitor treatment in chronic systolic heart failure

Henrike Arfsten et al.

Summary: The study aimed to investigate the impact of ARNi initiation on ADM regulation, and the results showed that following ARNi initiation, there was a significant increase in bio-ADM and MR-proADM concentrations, indicating enhanced formation and reduced breakdown of bioactive ADM with ARNi therapy, leading to activation of the ADM-axis.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)

Article Cardiac & Cardiovascular Systems

CDR132L improves systolic and diastolic function in a large animal model of chronic heart failure

Sandor Batkai et al.

Summary: In a chronic model of post-myocardial infarction heart failure, monthly administration of CDR132L improved cardiac function, reversed cardiac remodelling, and ameliorated diastolic function, indicating its safety and therapeutic efficacy for chronic heart failure treatment.

EUROPEAN HEART JOURNAL (2021)

Article Cardiac & Cardiovascular Systems

Genetic Variation in Enhancers Modifies Cardiomyopathy Gene Expression and Progression

Anthony M. Gacita et al.

Summary: This study identified enhancers that regulate cardiomyopathy gene expression by integrating epigenomic profiling from hearts and cardiomyocytes. Genomic variation within these enhancer regions is associated with cardiomyopathy progression over time, highlighting the importance of noncoding modifiers in cardiac diseases.

CIRCULATION (2021)

Article Cardiac & Cardiovascular Systems

Clonal haematopoiesis in chronic ischaemic heart failure: prognostic role of clone size for DNMT3A- and TET2-driver gene mutations

Birgit Assmus et al.

Summary: Somatic mutations of DNMT3A and TET2 in patients with chronic ischaemic heart failure were found to be associated with clonal haematopoiesis and poor prognosis. The study defined threshold levels for these mutations, indicating a worse outcome in patients with higher variant allele frequencies.

EUROPEAN HEART JOURNAL (2021)

Article Pharmacology & Pharmacy

Adrecizumab: an investigational agent for the biomarker-guided treatment of sepsis

Benjamin Deniau et al.

Summary: ADZ is the first humanized antibody targeting ADM, with potential use as a "biomarker-guided therapy" in septic patients. It is increasingly seen as a potential adjunct therapy to restore endothelial function in septic shock.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2021)

Review Cardiac & Cardiovascular Systems

Cellular signaling cross-talk between different cardiac cell populations: an insight into the role of exosomes in the heart diseases and therapy

Binh Yen Nguyen et al.

Summary: Exosomes enriched in bioactive molecules play crucial roles in mediating intercellular signaling in heart diseases, regulating cardiac physiological processes and potential for cardiac regeneration.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2021)

Review Cardiac & Cardiovascular Systems

Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches

Begona Lopez et al.

Summary: Diffuse myocardial fibrosis is a common lesion in chronic cardiac diseases, resulting from excessive deposition of collagen fibers throughout the myocardium. The composition and properties of the fibers play a role in the detrimental effects on cardiac function and clinical outcomes in patients with heart failure. Various clinicopathological phenotypes of diffuse myocardial fibrosis exist, and understanding the mechanisms and potential therapeutic strategies is essential for personalizing prevention and reversal in patients with heart failure.

NATURE REVIEWS CARDIOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Proteomic and Mechanistic Analysis of Spironolactone in Patients at Risk for HF

Joao Pedro Ferreira et al.

Summary: This study found that spironolactone exerts cardiovascular protective effects by reducing fibrosis, inflammation, thrombosis, congestion, and improving vascular function through multiple pathways, potentially slowing the progression toward heart failure.

JACC-HEART FAILURE (2021)

Article Cardiac & Cardiovascular Systems

Association Between Angiotensin Receptor-Neprilysin Inhibition, Cardiovascular Biomarkers, and Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction

Sean P. Murphy et al.

Summary: In this study, heart failure patients with reduced ejection fraction undergoing sacubitril/valsartan treatment for 12 months showed significant reductions in concentrations of NT-proBNP, hs-cTnT, and sST2. Changes in NT-proBNP and hs-cTnT were associated with left atrial and left ventricular reverse remodeling.

CIRCULATION-HEART FAILURE (2021)

Article Cardiac & Cardiovascular Systems

The combination of carboxy-terminal propeptide of procollagen type I blood levels and late gadolinium enhancement at cardiac magnetic resonance provides additional prognostic information in idiopathic dilated cardiomyopathy - A multilevel assessment of myocardial fibrosis in dilated cardiomyopathy

Anne G. Raafs et al.

Summary: By combining non-invasive and invasive methods along with blood biomarkers, the combination of LGE and PICP offers a more accurate prognostic value for patients with dilated cardiomyopathy, with gene expression showing an increase in pro-fibrotic and pro-inflammatory pathways in high fibrosis patients.

EUROPEAN JOURNAL OF HEART FAILURE (2021)

Review Biochemistry & Molecular Biology

VCAM-1 as a predictor biomarker in cardiovascular disease

Mayarling Francisca Troncoso et al.

Summary: VCAM-1 and sVCAM-1 have been proposed as biomarkers in immunological diseases, cancer, etc.; this review discusses the role of sVCAM-1 as a predictor of cardiovascular disease.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2021)

Review Cardiac & Cardiovascular Systems

Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC)

Wouter C. Meijers et al.

Summary: This review examined the most promising emerging biomarkers for the clinical assessment and management of patients with heart failure, including high-sensitivity cardiac troponins, procalcitonin, novel kidney markers, sST2, galectin-3, GDF-15, CD146, neprilysin, and ADM. Analytical considerations, diagnostic and prognostic performance, potential implementation in clinical algorithms, and ongoing clinical trials were discussed for each biomarker.

EUROPEAN JOURNAL OF HEART FAILURE (2021)

Article Cardiac & Cardiovascular Systems

AntimiR-132 Attenuates Myocardial Hypertrophy in an Animal Model of Percutaneous Aortic Constriction

Rabea Hinkel et al.

Summary: This study established a novel porcine model of pressure-overload-induced heart failure and found that inhibition of miR-132 has a significant effect on the development of heart failure.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

Review Cardiac & Cardiovascular Systems

Towards precision medicine in heart failure

Chad S. Weldy et al.

Summary: This review summarizes the biology of heart failure, highlighting the importance of genetic predisposition in individual patient for precision therapy. It discusses the causal relationships between genetic contributors and traditional structure-based remodelling outcomes, as well as the mechanisms of action of both traditional and novel therapeutics.

NATURE REVIEWS CARDIOLOGY (2021)

Article Cardiac & Cardiovascular Systems

The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart 'OMics' in AGEing (HOMAGE) randomized clinical trial

John G. F. Cleland et al.

Summary: The study showed that spironolactone had an impact on collagen synthesis and metabolism in high-risk individuals for heart failure, without interaction with serum galectin-3. Spironolactone treatment led to changes in type-I collagen metabolism.

EUROPEAN HEART JOURNAL (2021)

Article Cardiac & Cardiovascular Systems

Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study

Jorg Taubel et al.

Summary: The study evaluated the safety and mechanism of action of CDR132L in patients with chronic ischemic heart failure, showing that CDR132L is safe and well tolerated, effectively reducing miR-132 levels and improving cardiac function.

EUROPEAN HEART JOURNAL (2021)

Article Cardiac & Cardiovascular Systems

CDR132L improves systolic and diastolic function in a large animal model of chronic heart failure

Sandor Batkai et al.

Summary: The study aimed to evaluate the safety and efficacy of CDR132L in a clinically relevant large animal model of chronic heart failure after myocardial infarction. Results showed that CDR132L treatment significantly improved cardiac function and reversed cardiac remodeling, indicating its potential as a treatment for chronic heart failure.

EUROPEAN HEART JOURNAL (2021)

Article Cardiac & Cardiovascular Systems

Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study

Jorg Taubel et al.

Summary: The first-in-class miR-132 inhibitor, CDR132L, showed good safety and tolerability in HF patients. It effectively reduced miR-132 levels, decreased NT-proBNP levels, and potentially improved cardiac function.

EUROPEAN HEART JOURNAL (2021)

Review Cardiac & Cardiovascular Systems

Endothelin-1 levels and cardiovascular events

Matthew Jankowich et al.

TRENDS IN CARDIOVASCULAR MEDICINE (2020)

Review Cardiac & Cardiovascular Systems

The pathogenic role of coronary microvascular dysfunction in the setting of other cardiac or systemic conditions

Regina E. Konst et al.

CARDIOVASCULAR RESEARCH (2020)

Review Cardiac & Cardiovascular Systems

Coronary microvascular dysfunction in hypertrophy and heart failure

Paolo G. Camici et al.

CARDIOVASCULAR RESEARCH (2020)

Article Cardiac & Cardiovascular Systems

Pseudouridine and N-formylmethionine associate with left ventricular mass index: Metabolome-wide association analysis of cardiac remodeling

Alexander C. Razavi et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2020)

Review Cardiac & Cardiovascular Systems

Cellular cross-talks in the diseased and aging heart

Julian U. G. Wagner et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2020)

Article Cardiac & Cardiovascular Systems

S100A9 Links Inflammation and Repair in Myocardial Infarction

Goran Marinkovic et al.

CIRCULATION RESEARCH (2020)

Article Cardiac & Cardiovascular Systems

Aptamer-Based Proteomic Platform Identifies Novel Protein Predictors of Incident Heart Failure and Echocardiographic Traits

Matthew Nayor et al.

CIRCULATION-HEART FAILURE (2020)

Review Cardiac & Cardiovascular Systems

Omics phenotyping in heart failure: the next frontier

Antoni Bayes-Genis et al.

EUROPEAN HEART JOURNAL (2020)

Review Cardiac & Cardiovascular Systems

Soluble ST2 and Soluble Markers of Fibrosis: Emerging Roles for Prognosis and Guiding Therapy

Justin Sharim et al.

CURRENT CARDIOLOGY REPORTS (2020)

Review Biochemistry & Molecular Biology

Extracellular matrix-derived peptides in tissue remodeling and fibrosis

Lisandra E. de Castro Bras et al.

MATRIX BIOLOGY (2020)

Review Cardiac & Cardiovascular Systems

Cardiac natriuretic peptides

Jens P. Goetze et al.

NATURE REVIEWS CARDIOLOGY (2020)

Review Cardiac & Cardiovascular Systems

Growth differentiation factor 15 in adverse cardiac remodelling: from biomarker to causal player

Marian Wesseling et al.

ESC HEART FAILURE (2020)

Article Cardiac & Cardiovascular Systems

Epigenomes of Human Hearts Reveal New Genetic Variants Relevant for Cardiac Disease and Phenotype

Wilson Lek Wen Tan et al.

CIRCULATION RESEARCH (2020)

Article Cardiac & Cardiovascular Systems

Targeting muscle-enriched long non-coding RNA H19 reverses pathological cardiac hypertrophy

Janika Viereck et al.

EUROPEAN HEART JOURNAL (2020)

Article Cardiac & Cardiovascular Systems

Identifying temporal molecular signatures underlying cardiovascular diseases: A data science platform

Neo Chung Christopher et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2020)

Review Physiology

Novel roles of immunometabolism and nonmyocyte metabolism in cardiac remodeling and injury

Alan J. Mouton et al.

AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Effect of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFpEF

Jonathan W. Cunningham et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Review Cardiac & Cardiovascular Systems

Targeting Cyclic Guanosine Monophosphate to Treat Heart Failure JACC Review Topic of the Week

Michele Emdin et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Review Cardiac & Cardiovascular Systems

Finding a Needle in a Haystack Proteomics in Heart Failure

Sam A. Michelhaugh et al.

JACC-BASIC TO TRANSLATIONAL SCIENCE (2020)

Article Cardiac & Cardiovascular Systems

Reappraisal of Inflammatory Biomarkers in Heart Failure

Thanat Chaikijurajai et al.

CURRENT HEART FAILURE REPORTS (2020)

Article Medicine, Research & Experimental

Inflammatory extracellular vesicles prompt heart dysfunction via TRL4-dependent NF-kappa B activation

Vanessa Biemmi et al.

THERANOSTICS (2020)

Article Cardiac & Cardiovascular Systems

Effects of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFrEF

Michael R. Zile et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Article Cardiac & Cardiovascular Systems

Combining Circulating MicroRNA and NT-proBNP to Detect and Categorize Heart Failure Subtypes

Lee Lee Wong et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Article Cardiac & Cardiovascular Systems

Accelerating Biomarker Discovery Through Electronic Health Records, Automated Biobanking, and Proteomics

Quinn S. Wells et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Review Cardiac & Cardiovascular Systems

RNA-based diagnostic and therapeutic strategies for cardiovascular disease

Dongchao Lu et al.

NATURE REVIEWS CARDIOLOGY (2019)

Article Pharmacology & Pharmacy

The Quest for Antiinflammatory and Immunomodulatory Strategies in Heart Failure

Sophie Van Linthout et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)

Review Biochemistry & Molecular Biology

Human Circulating miRNAs Real-time qRT-PCR-based Analysis: An Overview of Endogenous Reference Genes Used for Data Normalization

Simone Donati et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Medicine, Research & Experimental

Long Noncoding RNA-Enriched Vesicles Secreted by Hypoxic Cardiomyocytes Drive Cardiac Fibrosis

Franziska Kenneweg et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2019)

Review Cell Biology

The role of microvesicles containing microRNAs in vascular endothelial dysfunction

Zeyu Shu et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)

Review Cardiac & Cardiovascular Systems

Clinical and Prognostic Significance of sST2 in Heart Failure JACC Review Topic of the Week

Alberto Aimo et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Review Cardiac & Cardiovascular Systems

Pericardial fluid: an underrated molecular library of heart conditions and a potential vehicle for cardiac therapy

Fabio Trindade et al.

BASIC RESEARCH IN CARDIOLOGY (2019)

Article Cardiac & Cardiovascular Systems

Comprehensive plasma and tissue profiling reveals systemic metabolic alterations in cardiac hypertrophy and failure

Oliver J. Mueller et al.

CARDIOVASCULAR RESEARCH (2019)

Review Cardiac & Cardiovascular Systems

Adrenomedullin in heart failure: pathophysiology and therapeutic application

Adriaan A. Voors et al.

EUROPEAN JOURNAL OF HEART FAILURE (2019)

Review Peripheral Vascular Disease

Endothelin: 30 Years From Discovery to Therapy

Matthias Barton et al.

HYPERTENSION (2019)

Article Cardiac & Cardiovascular Systems

NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF

Melissa A. Daubert et al.

JACC-HEART FAILURE (2019)

Review Immunology

Roles of Exosomes Derived From Immune Cells in Cardiovascular Diseases

Runda Wu et al.

FRONTIERS IN IMMUNOLOGY (2019)

Review Cardiac & Cardiovascular Systems

Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives

Wolfgang Poller et al.

EUROPEAN HEART JOURNAL (2018)

Article Cardiac & Cardiovascular Systems

Circulating microRNA-132 levels improve risk prediction for heart failure hospitalization in patients with chronic heart failure

Serge Masson et al.

EUROPEAN JOURNAL OF HEART FAILURE (2018)

Article Cardiac & Cardiovascular Systems

Myocardial infarction-induced microRNA-enriched exosomes contribute to cardiac Nrf2 dysregulation in chronic heart failure

Changhai Tian et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2018)

Review Medical Laboratory Technology

Novel heart failure biomarkers: why do we fail to exploit their potential?

Arnold Piek et al.

CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2018)

Letter Cardiac & Cardiovascular Systems

Bio-adrenomedullin as a potential quick, reliable, and objective marker of congestion in heart failure

Daan Kremer et al.

EUROPEAN JOURNAL OF HEART FAILURE (2018)

Review Cardiac & Cardiovascular Systems

Metabolic remodelling in heart failure

Edoardo Bertero et al.

NATURE REVIEWS CARDIOLOGY (2018)

Review Medicine, Research & Experimental

Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update

Navin Suthahar et al.

THERANOSTICS (2018)

Review Cardiac & Cardiovascular Systems

Established and Emerging Roles of Biomarkers in Heart Failure

Nasrien E. Ibrahim et al.

CIRCULATION RESEARCH (2018)

Article Cardiac & Cardiovascular Systems

Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction

Jasper Tromp et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)

Article Medicine, Research & Experimental

Plasma levels of heart failure biomarkers are primarily a reflection of extracardiac production

Weijie Du et al.

THERANOSTICS (2018)

Review Cardiac & Cardiovascular Systems

Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic Options JACC State-of-the-Art Review

Viviany R. Taqueti et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)

Editorial Material Multidisciplinary Sciences

Following hearts, one cell at a time: recent applications of single-cell RNA sequencing to the understanding of heart disease

Matthew Ackers-Johnson et al.

NATURE COMMUNICATIONS (2018)

Review Immunology

Cardioimmunology: the immune system in cardiac homeostasis and disease

Filip K. Swirski et al.

NATURE REVIEWS IMMUNOLOGY (2018)

Review Medical Laboratory Technology

Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease

Kai C. Wollert et al.

CLINICAL CHEMISTRY (2017)

Article Peripheral Vascular Disease

Phenotyping of myocardial fibrosis in hypertensive patients with heart failure. Influence on clinical outcome

Susana Ravassa et al.

JOURNAL OF HYPERTENSION (2017)

Article Medicine, General & Internal

Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease

S. Jaiswal et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Cell Biology

The long noncoding RNA Wisper controls cardiac fibrosis and remodeling

Rudi Micheletti et al.

SCIENCE TRANSLATIONAL MEDICINE (2017)

Article Critical Care Medicine

Adrenomedullin: a marker of impaired hemodynamics, organ dysfunction, and poor prognosis in cardiogenic shock

Heli Tolppanen et al.

ANNALS OF INTENSIVE CARE (2017)

Article Cardiac & Cardiovascular Systems

Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure A Meta-Analysis

Alberto Aimo et al.

JACC-HEART FAILURE (2017)

Review Medicine, General & Internal

The Soft-and Hard-Heartedness of Cardiac Fibroblasts: Mechanotransduction Signaling Pathways in Fibrosis of the Heart

Kate M. Herum et al.

JOURNAL OF CLINICAL MEDICINE (2017)

Review Cardiac & Cardiovascular Systems

Using biomarkers to guide heart failure management

Kay-Won Chang et al.

EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2017)

Review Pharmacology & Pharmacy

Circulating Biomarkers of Collagen Metabolism and Prognosis of Heart Failure with Reduced or Mid-Range Ejection Fraction

Joana Moura Ferreira et al.

CURRENT PHARMACEUTICAL DESIGN (2017)

Article Cardiac & Cardiovascular Systems

Exosomes secreted by cardiomyocytes subjected to ischaemia promote cardiac angiogenesis

Teresa M. Ribeiro-Rodrigues et al.

CARDIOVASCULAR RESEARCH (2017)

Article Cardiac & Cardiovascular Systems

Inhibition of the Cardiac Fibroblast- Enriched lncRNA Meg3 Prevents Cardiac Fibrosis and Diastolic Dysfunction

Maria-Teresa Piccoli et al.

CIRCULATION RESEARCH (2017)

Review Cardiac & Cardiovascular Systems

Circulating Noncoding RNAs as Biomarkers of Cardiovascular Disease and Injury

Janika Viereck et al.

CIRCULATION RESEARCH (2017)

Article Cardiac & Cardiovascular Systems

VEGF-Induced Expression of miR-17-92 Cluster in Endothelial Cells Is Mediated by ERK/ELK1 Activation and Regulates Angiogenesis

Aranzazu Chamorro-Jorganes et al.

CIRCULATION RESEARCH (2016)

Article Cardiac & Cardiovascular Systems

Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction

Michelle M. Y. Chan et al.

EUROPEAN JOURNAL OF HEART FAILURE (2016)

Review Nutrition & Dietetics

Sources and Functions of Extracellular Small RNAs in Human Circulation

Joelle V. Fritz et al.

ANNUAL REVIEW OF NUTRITION, VOL 36 (2016)

Review Cardiac & Cardiovascular Systems

Cardiac Fibrosis The Fibroblast Awakens

Joshua G. Travers et al.

CIRCULATION RESEARCH (2016)

Review Cardiac & Cardiovascular Systems

Chronic Heart Failure and Inflammation What Do We Really Know?

Sarah A. Dick et al.

CIRCULATION RESEARCH (2016)

Article Cardiac & Cardiovascular Systems

Myocardial Collagen Cross-Linking Is Associated With Heart Failure Hospitalization in Patients With Hypertensive Heart Failure

Begona Lopez et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)

Article Cell Biology

Long noncoding RNA Chast promotes cardiac remodeling

Janika Viereck et al.

SCIENCE TRANSLATIONAL MEDICINE (2016)

Review Medical Laboratory Technology

Data Normalization Strategies for MicroRNA Quantification

Heidi Schwarzenbach et al.

CLINICAL CHEMISTRY (2015)

Review Cardiac & Cardiovascular Systems

State of the Art: Newer biomarkers in heart failure

Rudolf A. de Boer et al.

EUROPEAN JOURNAL OF HEART FAILURE (2015)

Review Cardiac & Cardiovascular Systems

Crosstalk between fibroblasts and inflammatory cells

Sophie Van Linthout et al.

CARDIOVASCULAR RESEARCH (2014)

Article Cardiac & Cardiovascular Systems

Long Noncoding RNAs in Patients With Acute Myocardial Infarction

Melanie Vausort et al.

CIRCULATION RESEARCH (2014)

Article Cardiac & Cardiovascular Systems

Circulating Long Noncoding RNA, LIPCAR, Predicts Survival in Patients With Heart Failure

Regalla Kumarswamy et al.

CIRCULATION RESEARCH (2014)

Review Cardiac & Cardiovascular Systems

Role of Exosomes in Myocardial Remodeling

Anders Waldenstrom et al.

CIRCULATION RESEARCH (2014)

Article Medicine, Research & Experimental

Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy

Claudia Bang et al.

JOURNAL OF CLINICAL INVESTIGATION (2014)

Article Multidisciplinary Sciences

A long noncoding RNA protects the heart from pathological hypertrophy

Pei Han et al.

NATURE (2014)

Article Cardiac & Cardiovascular Systems

Vascular Endothelial Adrenomedullin-RAMP2 System Is Essential for Vascular Integrity and Organ Homeostasis

Teruhide Koyama et al.

CIRCULATION (2013)

Article Cardiac & Cardiovascular Systems

Pathological Ventricular Remodeling: Mechanisms: Part 1 of 2

Jana S. Burchfield et al.

CIRCULATION (2013)

Article Cardiac & Cardiovascular Systems

Biomarkers of Chronic Cardiac Injury and Hemodynamic Stress Identify a Malignant Phenotype of Left Ventricular Hypertrophy in the General Population

Ian J. Neeland et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)

Article Medicine, Research & Experimental

Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis

Feng Wang et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2013)

Article Cardiac & Cardiovascular Systems

Inhibition of miR-15 Protects Against Cardiac Ischemic Injury

Thomas G. Hullinger et al.

CIRCULATION RESEARCH (2012)

Review Cardiac & Cardiovascular Systems

A contemporary view on endothelial function in heart failure

Eduard Shantsila et al.

EUROPEAN JOURNAL OF HEART FAILURE (2012)

Review Cardiac & Cardiovascular Systems

S100A8/A9 complex as a new biomarker in prediction of mortality in elderly patients with severe heart failure

Li-Ping Ma et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2012)

Article Multidisciplinary Sciences

Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function

Bianca C. Bernardo et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Article Multidisciplinary Sciences

The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy

Ahmet Ucar et al.

NATURE COMMUNICATIONS (2012)

Article Cardiac & Cardiovascular Systems

Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome

Christian Widera et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)

Article Cardiac & Cardiovascular Systems

Diastolic Tissue Doppler Indexes Correlate With the Degree of Collagen Expression and Cross-Linking in Heart Failure and Normal Ejection Fraction

Mario Kasner et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)

Review Cardiac & Cardiovascular Systems

Clinical, Molecular, and Genomic Changes in Response to a Left Ventricular Assist Device

Jennifer L. Hall et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)

Article Cardiac & Cardiovascular Systems

MicroRNA-210 as a Novel Therapy for Treatment of Ischemic Heart Disease

Shijun Hu et al.

CIRCULATION (2010)

Article Cardiac & Cardiovascular Systems

Circulating microRNAs are new and sensitive biomarkers of myocardial infarction

Yuri D'Alessandra et al.

EUROPEAN HEART JOURNAL (2010)

Article Cardiac & Cardiovascular Systems

Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans

Guo-Kun Wang et al.

EUROPEAN HEART JOURNAL (2010)

Article Medicine, General & Internal

Association of Troponin T Detected With a Highly Sensitive Assay and Cardiac Structure and Mortality Risk in the General Population

James A. de Lemos et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)

Article Cardiac & Cardiovascular Systems

Mid-Region Pro-Hormone Markers for Diagnosis and Prognosis in Acute Dyspnea Results From the BACH (Biomarkers in Acute Heart Failure) Trial

Alan Maisel et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)

Review Cardiac & Cardiovascular Systems

Troponin Elevation in Heart Failure Prevalence, Mechanisms, and Clinical Implications

Robb D. Kociol et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)

Article Cardiac & Cardiovascular Systems

Serum Soluble ST2 A Potential Novel Mediator in Left Ventricular and Infarct Remodeling After Acute Myocardial Infarction

Robin A. P. Weir et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)

Review Cardiac & Cardiovascular Systems

Galectin-3: a novel mediator of heart failure development and progression

Rudolf A. de Boer et al.

EUROPEAN JOURNAL OF HEART FAILURE (2009)

Article Cardiac & Cardiovascular Systems

Osteopontin, a New Prognostic Biomarker in Patients With Chronic Heart Failure

Mark Rosenberg et al.

CIRCULATION-HEART FAILURE (2008)

Review Biochemistry & Molecular Biology

Molecular regulation of cardiac hypertrophy

Sean P. Barry et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)

Article Medicine, General & Internal

Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure - The VERITAS Randomized controlled trials

John J. V. McMurray et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)

Article Biochemistry & Molecular Biology

MicroRNA-133 controls cardiac hypertrophy

Alessandra Care et al.

NATURE MEDICINE (2007)

Article Multidisciplinary Sciences

Control of stress-dependent cardiac growth and gene expression by a microRNA

Eva van Rooij et al.

SCIENCE (2007)

Article Cardiac & Cardiovascular Systems

Effects of loor diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure

B López et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)

Article Peripheral Vascular Disease

Role of endothelin-1 in hypertension and vascular disease

EL Schiffrin

AMERICAN JOURNAL OF HYPERTENSION (2001)

Review Cardiac & Cardiovascular Systems

Endothelial dysfunction in cardiovascular diseases - The role of oxidant stress

H Cai et al.

CIRCULATION RESEARCH (2000)